openPR Logo
Press release

Janssen Pharmaceutica NV and Proteros expand relationship and enter into Global Agreement

01-10-2012 04:24 AM CET | Health & Medicine

Press release from: Proteros biostructures GmbH

Martinsried Jan 09, 2012. Janssen Research & Development, a division of Janssen Pharmaceutica NV (“Janssen”) and Proteros biostructures GmbH (“Proteros”) today announced they have entered into a long-term global service agreement granting Janssen privileged access to Proteros portfolio of discovery technologies and services.

Under the agreement Janssen will have broad access to Proteros’ drug discovery technologies, including structural biology, biophysical screening and profiling service, novel fragment libraries, medicinal chemistry expertise and fully integrated structure-based lead discovery programs to identify small molecule inhibitors. This is a consolidation of the services Proteros has provided over the past eight years in support of Janssen discovery research efforts in the USA and Europe.

Dr Torsten Neuefeind, Chief Executive Officer for Proteros commented “it is an important milestone for Proteros that the work performed by our scientists to support Janssen global discovery research is recognized as being of such high value that is has developed into this strategic collaboration. Proteros looks forward to contributing innovations and high quality science that makes a positive impact on Janssen’s research success”.

About Proteros

Proteros is a privately held company, which provides services and proprietary technologies to support integrated drug discovery. The company accelerates and improves protein structure analysis and structure-based drug discovery with its expertise, industrialized processes and unique technologies for crystallography and fragment-based lead generation. Proteros complements its clients’ internal capabilities with external expertise and access to flexible resources. Proteros currently provides services for more than 80 pharmaceutical and biotechnology clients in North America, Europe and Asia.

For further information please visit the website at: www.proteros.com

Proteros biostructures GmbH
Thomas Waldmann, Ph.D.
Bunsenstrasse 7a
D-82152, Martinsried
Germany
Phone: +49 89 7007 61 – 0
E-Mail: business@proteros.com
Internet: www.proteros.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Janssen Pharmaceutica NV and Proteros expand relationship and enter into Global Agreement here

News-ID: 206470 • Views: 1842

More Releases from Proteros biostructures GmbH

PROTEROS ANNOUNCES SUCCESSFUL CLOSE OF FINANCING ROUND
Largest-ever Financing allows for Expansion of Drug Discovery Capabilities MARTINSRIED, GERMANY (August 6th, 2012) – Proteros biostructures GmbH (‘Proteros’) announced today that it had successfully closed a financing round of five million Euros to fund the continued expansion and growth of the company. The financing round was led by BayBG, a key equity investor for Proteros. The financing round is the third and largest investment into the firm since the inception
Proteros and Eisai Co., Ltd enter into Integrated Lead Discovery Collaboration
Martinsried (Germany), April 16, 2012. Proteros biostructures GmbH today announced that the company has entered into a research collaboration with Eisai Co., Ltd (Japan) to identify small molecule inhibitors against a target selected by Eisai in the field of immunology. Under the agreement Proteros will deliver a novel lead compound applying its integrated lead discovery platform that includes X-Ray structural biology, biophysical screening and profiling, novel fragment libraries and medicinal chemistry
Proteros announces the appointment of Dr. Klaus Hinterding as Chief Scientific O …
Martinsried, Germany, February 9, 2012. Proteros biostructures GmbH (Proteros) announced today that Dr. Klaus Hinterding, formerly at Hoffmann-La Roche Ltd. (Roche), has joined the company as Chief Scientific Officer and member of the management board. Dr. Hinterding brings to Proteros considerable pharmaceutical industry experience that spans early research through to clinical development in various therapeutic areas. At Novartis, his research contributed to the understanding of the mode-of-action of GilenyaTM, licensed for
Proteros has relocated to a tailor-made facility in Martinsried
Martinsried, October 24th 2011. Proteros biostructures GmbH is further extending its business capacities by moving into a new building in Munich-Martinsried, one of the leading Biotech locations in Germany. After a two-year planning period, Proteros has reached an important milestone in its development by centralizing all operations within a purpose-built facility. The 4,000 square-meter of laboratory and office space, worth a total of about 15 M €, has been optimally designed

All 5 Releases


More Releases for Jan

New Book By Jan Marin Tramontano: What Love Becomes
ADELAIDE BOOKS is proud to offer the latest work by Jan Marin Tramontano What Love Becomes hitting stores everywhere on February 7th, 2019. What Love Becomes is a work of literary fiction that traces the intimate landscape of two contemporary marriages from their idealistic, yet misguided beginnings. Each couple mistakenly believes their happily ever after will come without really knowing who’ve they’ve married. What begins as self-deception quickly morphs into deception
Datamax-O’Neil Appoints Jan Mariën Product Manager EMEA
Experienced expert for printing solutions supports customized product development for the EMEA market BOURG-LÈS-VALENCE, FRANCE – Datamax-O’Neil, a leading manufacturer of stationary, vehicle mount, portable label and receipt printers, has named Jan Mariën as Product Manager EMEA. The new position has been created to even better fulfil the special requirements of customers in Europe, the Middle East and Africa. Jan Mariën is managing the development of Datamax-O’Neil’s product lines in the
Jan Sundahl Joins RE/MAX Alliance Group in Sarasota, Florida
SARASOTA, FLORIDA – Realtor Jan Sundahl has joined RE/MAX Alliance Group in the University Office. Sundahl has 18 years of real estate experience, and has lived in East County Sarasota for 15 years, giving her a strong knowledge of East County communities and neighborhoods. Formerly with RE/MAX Properties, which has since merged to form RE/MAX Alliance Group, she has been awarded the RE/MAX Executive Club award and was a three-time
Jan Beckers, Tim Koschella and Team Europe found HitFox
Berlin, Germany, 12 August 2011: HitFox will launch in Germany on-time for the gamescom 2011. HitFox specializes in user acquisition for game publishers around the world. HitFox users can find exclusive deals for selected games and hardware at www.hitfox.de. Publishers will benefit in two different aspects: On one hand, no fix costs for the acquisition of new customers, on the other, they will receive a target group of passionate gamers
Application window for college financial aid opened Jan. 1
Colorado's CollegeInvest tells students to send their federal application ASAP January 7, 2010, Denver, CO – January 1 was the opening window for students to begin to apply for college financial assistance using the Free Application for Federal Student Aid (FAFSA). The FAFSA can be submitted through June but CollegeInvest, Colorado's not-for-profit higher education financing resource, encourages parents and students to submit their forms as early as possible because most financial aid
Intel Teach endorsed by EU Commissioner Jan Figel
At the high-level European EMINENT Conference in Brussels, held from Dec 06-07 2007, EU Commissioner Ján Figel, responsible for Education, Training, Culture and Youth, stressed the importance of a methodological approach in Professional Development for Teachers. “Digital Competence is a pre-requisite to learn learning” he said in front of over 250 delegates from around the world. “Learning to learn is a crucial competence for teachers, who are the most critical